CREBBP and acute lymphoblastic leukemia: CREBBP-mutated 697 cells were not differentially sensitive to traditional cytotoxic chemotherapy, and paradoxically showed a degree of sensitization to the glucocorticoid Dexamethasone, used in current ALL induction regimens (Fig. 1b and Supplementary Data Table 1 and Fig. 1b)4,11,12.